Pick of the Week - Dr Reddy’s Laboratories Ltd
Dr Reddy’s Laboratories Ltd (DRREDDY) is a global pharmaceutical company committed to providing access to affordable and innovative medicines.
566 Views
Dr. Reddy’s Laboratories Ltd - New Launches to Add Growth and Profitability!
The growth was driven by the launch of gRevlimid in the US and sequential improvement in Russian sales, which was only partially offset by price...
126 Views
Pharma Q2fy23 Preview
The Pharma universe under our coverage could report aggregate Revenue/EBITDA/PAT growth of 5.6%/-4.8%/-2.2% YoY. Currency (Rs) has depreciated by 5.0%
148 Views
Dr. Reddy's Laboratories - Management Meet Update
We hosted the management of Dr. Reddy’s Laboratories Ltd at our Annual Investor Conference to discuss the business outlook. The company expects to...
201 Views
Dr. Reddy's Laboratories - Strong Growth Across Business Segments
We reiterate our Buy rating on Dr. Reddy’s Laboratories (DRL) with a target price (TP) of Rs5,424. 4QFY22 earnings performance was above expectations
217 Views